FY2021
Millennium option opens a new path
A six-month option provided a route to a later earn-in. Triumph’s sale generated cash but also left milestone-dependent consideration, not an unconditional cash balance.
ASX: MBK · Five-year financial review
(ASX: MBK) Metal Bank Limited Financial Review - FY2021~25
Metal Bank’s five-year story is a shift in exploration assets, funding and write-downs—not a mine-sales cycle. The Triumph contingent asset dominated the FY2023 loss, Jordan service shares shaped FY2024 costs, and a Jordan exploration write-off affected FY2025. Cash remained tight even though the Group carried substantial project assets.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
FY2025 closing cash
A$0.395m
Reported June balance, not future funding.
FY2025 exploration asset
A$15.341m
Accounting carrying amount, not sale value.
FY2023 Triumph impairment
A$6.000m
Noncash loss of contingent consideration.
FY2025 Jordan write-off
A$1.147m
Exploration asset expense.
Five years in context
Livingstone and the Millennium earn-in expanded the Australian portfolio before the company pursued Middle East opportunities. The financial effects arrived in different places: acquisition cost in exploration assets, shares and cash in funding, and later write-downs in profit or loss.
As an explorer without product-sales revenue, MBK is better understood through funding, cash use and recoverability of project assets than a mining-margin trend. A resource estimate and an accounting carrying amount describe different things; neither establishes future cash receipts.
Events behind the numbers
FY2022
Livingstone acquisition and equity funding
The company acquired the 75% Livingstone interest and entered the Millennium earn-in. Large cash equity receipts supported both acquisition payments and exploration.
FY2023
Triumph impairment and an earned stake
The contingent Triumph asset was fully impaired. Millennium Stage 1 was completed, establishing a 51% interest; a further interest remained subject to Stage 2 expenditure.
FY2024
Jordan work and noncash service shares
Middle East field programs advanced. Shares issued for Jordan services were a major expense, while the entitlement offer and placement supplied cash funding.
FY2025
Portfolio reset and another entitlement offer
The accounts include the Jordan write-off, with withdrawal announced after year-end. A Saudi JV was established and the fully subscribed entitlement offer supplied additional equity cash.
FINANCIAL REVIEW / 01
The loss trend hides different kinds of expense
The FY2023 loss spike was dominated by the full impairment of contingent consideration from the earlier Triumph sale. The issuer judged the first resource milestone unlikely to be achieved. That financial-asset loss did not represent the same amount of cash spent on current exploration.
The following years have a different mix: FY2024 share-based payments include Jordan service shares, while FY2025 includes a capitalised-exploration write-off. FY2022 also carried project-development consulting expense. A smaller total loss alone therefore does not measure an equivalent improvement in recurring cash costs.
Statutory loss after tax
A$ million
Loss after income tax
AI-generated presentation · values from Five-year statutory result and non-sales income; no missing values plotted as zero.
Share-based payment expense
A$ million
Share-based payment expense
AI-generated presentation · values from Share-based payments and exploration write-offs: FY2022–FY2025; no missing values plotted as zero.
Five-year statutory result and non-sales income
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after income tax | (0.364) | (1.893) | (7.045) | (2.224) | (2.116) |
| Revenue and other income / other income | 0.106276 | 0.000835 | 0.018688 | 0.003028 | 0.004620 |
FY2021 income includes government subsidies, a drilling grant and interest; the later income figures are interest, not mine-product sales.
Loss after tax is used, not total comprehensive loss including foreign-currency translation. FY2024–FY2025 attribution rows in the retained records reproduce the comprehensive total; these are not substituted for statutory profit or loss.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The recurring expense lines behind the reported loss
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Administration / other expenses | (0.105) | (0.172) | (0.165) | (0.219) | (0.229) |
| Employee benefits charged to profit or loss | (0.041) | (0.162) | (0.160) | (0.154) | (0.014) |
| Compliance and regulatory expenses | (0.127) | (0.159) | (0.143) | (0.139) | (0.145) |
| Directors fees | (0.070) | (0.119) | (0.135) | (0.135) | (0.115) |
| Management and consulting fees | (0.127) | (0.195) | (0.117) | (0.275) | (0.087) |
Expenses are signed amounts. FY2025 labels the first line “Other expenses”; prior editions use “Administration expenses”. These are selected reported categories, not an all-cost subtotal.
Employee expense is after capitalisation and is not total salaries paid. FY2021 personnel-note amounts differ slightly from the P&L line; the statutory P&L amount is retained without manufacturing a reconciled staff bridge.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Share-based payments and exploration write-offs: FY2022–FY2025
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Share-based payment expense | (0.373) | (0.324) | (1.269) | (0.381) |
| Exploration expenditure written off | (0.005) | 0.000 | 0.000 | (1.147) |
FY2024 share-based payments include A$1.006262m of shares for services in Jordan. This is separate from the FY2025 write-off of capitalised Jordan exploration.
FY2023 also includes the separate A$6.000m impairment of the Triumph contingent financial asset. It is not an exploration-asset write-off and is discussed below.
FY2021 is not appended to the stand-alone share-based-payment series: its personnel/P&L presentation differs. No nil total share-based compensation is implied.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 02
Lower personnel expense does not mean lower gross employment costs
Most FY2025 gross employment cost was capitalised into exploration assets, leaving a much smaller employee charge in profit or loss. Gross cost itself rose. Reading only the employee P&L line would obscure that change in where costs were recognised.
Why the employee P&L line fell: capitalisation matters
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Gross wages, superannuation and related costs | 0.314 | 0.331 |
| Less capitalised exploration costs | (0.160) | (0.317) |
| Net personnel cost in profit or loss | 0.154 | 0.014 |
Gross employment costs increased while substantially more was capitalised into exploration. The lower P&L charge is not evidence of an equivalent fall in payroll or cash expenditure.
Share-based payment expense is separately reported above and is not added to this net-personnel subtotal.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 03
Equity replenished cash, but did not remove the funding constraint
Operating and investing cash flows were negative throughout the review. FY2022 equity receipts created a cash buffer; FY2023 then used cash without new financing receipts. The placement disclosed after FY2023 year-end belongs to the later period, not the nil FY2023 financing column.
Cash acquisition payments explain part of the investing outflow: Livingstone’s initial cash consideration was followed by payment of the deferred instalment. By FY2025 the investing total was exploration cash expenditure, while cash equity receipts again partly replenished operating and investing outflows.
The company also disclosed a related-party facility in FY2023, but it was undrawn at that reporting date. It is not added to cash or treated as drawn borrowing. The FY2025 going-concern assessment still depended on additional equity and cost reduction; the auditor highlighted material uncertainty without modifying the opinion.
Operating, investing and financing cash flow
A$ million
Net operating cash flowNet investing cash flowNet financing cash flow
AI-generated presentation · values from Five-year cash flow: financing was nil in FY2023; no missing values plotted as zero.
Five-year cash flow: financing was nil in FY2023
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net operating cash flow | (0.479) | (1.391) | (0.566) | (0.764) | (0.770) |
| Net investing cash flow | (1.194) | (3.550) | (4.358) | (1.829) | (1.102) |
| Net financing cash flow | 2.046 | 9.630 | 0.000 | 2.621 | 1.474 |
FY2023 financing is explicitly nil in the original schedule’s explanation and the FY2024 comparative; it is not a missing period.
FY2021 uses the reported cash-flow face total. A$9 separates that observation from the reconciliation-note total; neither has been silently overwritten. Both round to A$0.479m outflow here.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Cash-use and equity-funding components
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Payments to suppliers and employees | (0.585) | (1.392) | (0.585) | (0.768) | (0.775) |
| Exploration and evaluation cash payments | (1.594) | (1.050) | (2.858) | (1.786) | (1.102) |
| Cash proceeds from shares and options | 2.112 | 10.100 | 0.000 | 2.714 | 1.562 |
| Cash share-issue costs | (0.065) | (0.470) | 0.000 | (0.093) | (0.087) |
FY2021 investing also includes A$0.400m project-sale receipts. FY2022 and FY2023 include A$2.500m and A$1.500m exploration-asset purchase payments respectively; FY2024 includes A$0.043359m PPE purchases.
These components explain, but are not additional to, the net cash-flow totals. Cash issue costs exclude noncash issue costs; accounting share capital is not a substitute for cash proceeds.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 04
A substantial asset base is not the same as liquid funding
Exploration assets dominate the later balance sheet. The FY2022 acquisition uplift included noncash and deferred consideration, while the FY2023 removal of the Triumph financial asset depressed total assets. These movements cannot be explained by exploration cash payments alone.
The nearly unchanged FY2025 exploration balance masks continued capitalised spending offset by the Jordan write-off. The retained assets remain subject to recoverability judgements; resource growth does not automatically turn their carrying value into cash.
Closing cash and total equity
A$ million
Cash and cash equivalentsTotal equity / net assets
AI-generated presentation · values from Group assets, liabilities, equity and liquidity; no missing values plotted as zero.
Exploration carrying value
A$ million
Closing exploration and evaluation asset
AI-generated presentation · values from Exploration expenditure versus the asset carried forward; no missing values plotted as zero.
Group assets, liabilities, equity and liquidity
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 1.001 | 5.690 | 0.766 | 0.793 | 0.395 |
| Total assets | 10.968 | 22.632 | 14.399 | 16.273 | 15.767 |
| Total liabilities | 0.166 | 2.290 | 0.398 | 0.630 | 0.360 |
| Total equity / net assets | 10.802 | 20.342 | 14.001 | 15.643 | 15.407 |
| Issued share capital | 22.879 | 33.715 | 34.263 | 38.172 | 39.919 |
All figures are consolidated Group amounts, not the parent-only balance sheet. FY2025 total assets are explicitly preserved in the supporting explanation of the balance-sheet record.
Issued capital is an accumulated equity-account balance, not current-year cash raised. Noncash acquisition/service shares and transfers from reserves can increase it.
FY2025 liabilities comprise current unsecured trade and other payables. There is no separately supported five-year borrowing series here; no missing debt value has been changed to zero.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Exploration expenditure versus the asset carried forward
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Current-year expenditure capitalised | 1.594 | 1.544 | 2.445 | 1.786 | 1.102 |
| Closing exploration and evaluation asset | 3.829 | 10.804 | 13.599 | 15.385 | 15.341 |
FY2022 also added A$5.431250m of project acquisition cost; FY2023 added A$0.350m. Acquisition costs can include shares and deferred consideration and need not match cash purchase payments.
Capitalised current-year costs differ from exploration cash payments through accounting classification and timing. Neither is a mineral-resource valuation or a production measure.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 exploration balance: work continued despite the write-off
A$ million
| Metric | FY2025 |
|---|---|
| Opening exploration and evaluation asset | 15.385 |
| Current-year capitalised expenditure | 1.102 |
| Jordan exploration write-off | (1.147) |
| Closing exploration and evaluation asset | 15.341 |
Opening asset plus additions less the write-off reconciles to the closing balance. The almost flat closing amount conceals both new expenditure and an exit decision.
Withdrawal from Jordan was announced on 15 August 2025, after balance date; the annual accounts nevertheless recognise the write-off in FY2025.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FINANCIAL REVIEW / 05
Project progress comes with milestones and different ownership interests
The Livingstone project was acquired at a 75% interest. Its later resource update is project-level evidence, not automatically MBK-attributable ounces. Separate contingent payments remain tied to specified resource thresholds. They should not be confused with the Triumph milestone receivable that was impaired.
Millennium’s completed Stage 1 established a 51% JV interest, with the additional 29% tied to Stage 2 expenditure. Ownership of the wholly owned corporate subsidiary is not 100% ownership of the underlying project. The Saudi JV introduced a separate 60% interest during FY2025.
After balance date, the company described an agreement to acquire Hastings gold assets with share consideration. It is not included as a June acquisition cash outflow. No FY2025 dividend was paid or recommended, and potential deferred tax assets were not recognised because their realisation was not considered probable.
Reading the figures
- Amounts are Group statutory observations. Whole Australian dollars are presented as A$ million; small income amounts retain extra precision.
- FY2023 financing and the related share/cost cash components are explicit nil. An undrawn facility is not drawn debt; missing standalone debt disclosures are not filled with zero.
- FY2021 personnel-note figures do not fully agree with the P&L presentation, and cash-flow observations differ by small dollar amounts. Reported P&L and face cash-flow selections are retained, with no forced restatement.
- FY2024–FY2025 statutory net loss is distinguished from comprehensive loss. Project resources, ownership interests, acquisition carrying costs and conditional payments are not collapsed into one valuation.
- The Millennium grant amount and a subsequent-event fundraising date are inconsistent in saved descriptions; neither is used to imply available funding. Subsequent acquisition and withdrawal announcements remain outside the balance-date cash figures.
- Prepared from existing year-by-year extraction records only. No raw-source retrieval, database query, financial web research or MiniMax call. GPT review against saved extractions; not an independent original-document audit.
Annual-report source registry
- Metal Bank Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Metal Bank Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Metal Bank Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Metal Bank Limited - Annual Report to shareholdersExisting annual extraction, including separately identified historical comparatives.
- Metal Bank Limited - Annual Report to ShareholdersExisting annual extraction, including separately identified historical comparatives.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.